Are TNF inhibitors still the agent of choice for RA?

被引：0
|
作者：
Taylor, Peter C. [1 ]
机构：
[1] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskeleta, Oxford, England
来源：
NATURE REVIEWS RHEUMATOLOGY | 2023年
关键词：
RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; METHOTREXATE; COMBINATION; ADALIMUMAB;
D O I：
10.1038/s41584-023-01043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Since entering the clinic 25 years ago, biologic TNF inhibitors have transformed the outlook for people with rheumatoid arthritis and set the standard for all other targeted therapies. Despite changes to the therapeutic landscape, TNF inhibitors look set to remain an important treatment option for the foreseeable future.
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis
    Taylor, Peter C.
    Feldmann, Marc
    NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (10) : 578 - 582
  • [22] Comment on the choice of TNF inhibitors [Stellungnahme zur präparatewahl bei TNF-inhibitoren]
    Manger B.
    Zeitschrift für Rheumatologie, 2005, 64 (2) : 88 - 89
  • [23] Direct cost of patients on TNF-α inhibitors for the treatment of rheumatoid arthritis (RA).
    Kerney, D
    Ollendorf, D
    Yu, EB
    Woolley, JM
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S509 - S509
  • [24] Effectiveness of TNF inhibitors in RA patients with moderate vs high disease activity
    Keystone, E.
    Reed, G.
    Hooper, M.
    Greeberg, J.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S779 - S779
  • [25] ANTINUCLEAR ANTIBODY POSITIVITY IN RA PATIENTS AND ITS IMPACT ON PERSISTENCY OF TNF INHIBITORS
    Sung, Y. -K.
    Cho, S. -K.
    Kim, D.
    Won, S.
    Choi, J. I.
    Choi, C. -B.
    Kim, T. -H.
    Jun, J. -B.
    Yoo, D. -H.
    Bae, S. -C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 629 - 629
  • [26] Power Dopper Ultrasonography Detects Superior Efficacy of Non-TNF Biologics Compared to Cycling of TNF Inhibitors in RA Patients Inadequate Response to First TNF Inhibitors
    Nishino, Ayako
    Kawashiri, Shinya
    Yoshitama, Tamami
    Eiraku, Nobutaka
    Matsuoka, Naoki
    Ueki, Yukitaka
    Okada, Akitomo
    Hamada, Hiroaki
    Hidaka, Toshihiko
    Nagano, Shuji
    Tsuru, Tomomi
    Fujikawa, Keita
    Arinobu, Yojiro
    Tada, Yoshifumi
    Nagata, Yasuhiro
    Kawakami, Atsushi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [27] Disease activity-guided TNF inhibitor dose reduction was noninferior to continuing TNF inhibitors for RA flares
    Ramirez-Lafita, Francisco
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
  • [28] Still a choice
    Holland, R
    NEW REPUBLIC, 2000, 223 (14) : 9 - 9
  • [29] Efficacy of rituximab in active RA patients with an inadequate response to one or more TNF inhibitors
    Kremer, J. M.
    Kvien, T. K.
    Tony, H.
    Tak, P. P.
    Luggen, M.
    Mariette, X.
    Hessey, E.
    McCabe, D.
    Safa-Leathers, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 40 - 40
  • [30] Efficacy of rituximab in active RA patients with an inadequate response toone or more TNF inhibitors
    Kremer, J. M.
    Maksymowych, W. P.
    Tony, H.
    Tak, P. P.
    Luggen, M.
    Mariette, X.
    Hessey, E.
    McCabe, D.
    Safa-Leathers, S.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1611 - 1611
12345